Clinical Trial Update: Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of letrozole monotherapy as second-line endocrine therapy in postmenopausal women with advanced breast cancer w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Postmenopausal Women With Advanced Breast Cancer | Phase 2 | Status: COMPLETED